Modeling Parkinson's disease falls associated with brainstem cholinergic systems decline.

Area of Science:

• Neuroscience
• Neurology
• Movement Disorders

Background:

• Parkinson's disease (PD) often involves gait instability and falls, affecting ~50% of patients.
• Brainstem cholinergic pedunculopontine nucleus (PPN) degeneration is implicated in PD gait issues.
• Previous work linked striatal dopamine (DA) and basal forebrain (BF) cholinergic cell loss to falls in rats.

Purpose of the Study:

• To investigate the combined effects of PPN cholinergic, striatal DA, and BF cholinergic cell loss on falls in a rat model.
• To determine if PPN lesions exacerbate gait impairments and falls caused by other neurochemical deficits.

Main Methods:

• Selective cholinergic lesions of the PPN were induced in rats.
• Lesions were combined with striatal DA depletion or BF cholinergic cell loss.
• Rats were tested on dynamic surfaces to assess traversal speed, slips, and falls.

Main Results:

• All lesion combinations including BF cholinergic system loss increased slips and falls.
• Combined PPN, BF cholinergic, and DA loss did not worsen falls compared to combined BF cholinergic and DA loss.
• BF cholinergic-striatal disruption appears critical for attentional-motor deficits causing falls.

Conclusions:

• The basal forebrain cholinergic system's interaction with striatal dopamine is a primary driver of falls in this PD model.
• Additional PPN cholinergic neuron loss may affect posture and gait in ways not measured by current tests.